Pharmacies have experienced a 30 per cent real terms funding reduction since 2015. The proposed increase in the national living wage (NLW) is expected to impose an implementation cost of £150 million to £195 million on the community pharmacy sector, Community Pharmacy England (CPE) has warned. Chancellor Jeremy Hunt recently announced a 9.8 per cent <p>The post Living wage hike to incur up to £195 million in costs for pharmacy sector: CPE first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

Female deaths by suicide are increasing at a higher rate than male deaths in England   The Department of Health and Social Care (DHSC) on Thursday (30th November) announced the launch of a new suicide surveillance system, bolstering its efforts to tackle emerging methods of suicide and clamp down on those seeking to sell dangerous <p>The post UK government launches new suicide surveillance system first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

There are over 50,000 additional nurses working in the NHS, compared to September 2019 NHS England delivered 358 million general practice (GP) appointments, including Covid-19 vaccinations, in the 12 months to October 2023, an increase of 50.9 million compared to October 2019. This equals to 44 more appointments per practice per working day, with over <p>The post 50 million more GP appointments delivered this year first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

These include powerful opioid painkillers and antidepressants, as well as unlicensed versions of erectile dysfunction drugs The Criminal Enforcement Unit (CEU) of the Medicines and Healthcare products Regulatory Agency (MHRA) seized a large quantity of suspected illegally traded medicines, including powerful prescription-only medicines, during raids conducted at two residential and two business premises across North <p>The post Thousands of illicit medicines seized in Manchester first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

Pharmacists can now initiate oral contraception and trained members of the pharmacy team can deliver blood pressure checks, with the expansion of the Pharmacy Contraception Service and the Hypertension Case-Finding Service coming into force from today (1 December 2023). As well as initiating oral contraception, pharmacists can continue to provide ongoing management of oral contraception The post Expanded contraception and hypertension pharmacy services go live appeared first on The Pharmacist.

Pharmacy teams should be prepared to discuss the current warnings and upcoming measures with their patients The General Pharmaceutical Council (GPhC) on Thursday sent an email to all pharmacy professionals to update them about a Valproate National Patient Safety Alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA). From January 2024, the MHRA <p>The post Valproate National Patient Safety Alert – GPhC tells what pharmacists need to do first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

Drafts of the 23 patient group directions (PGDs) and one protocol for the Pharmacy First service have now been published by NHS England. This follows the release earlier in the week of service specifications and the clinical pathways for the seven common conditions included in the scheme – uncomplicated urinary tract infection (UTI) in women, The post NHS England releases PGDs for Pharmacy First service appeared first on The Pharmacist.

The number of norovirus, flu and RSV infections are likely to increase further this week due to cold weather, warns Professor Sir Stephen Powis Winter pressures are already mounting on NHS staff ahead of December, with high levels of demand in hospitals due to a significant increase in cases of norovirus infection. Norovirus is a <p>The post Cases of norovirus in England almost tripled last week first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

There are currently ‘no plans’ to add to the seven common conditions covered by the incoming Pharmacy First service, the government has confirmed. Responding to a series of written questions from Peter Dowd, Labour MP for Bootle, the new pharmacy minister Andrea Leadsom outlined details of the service, listing the seven conditions – sinusitis, sore The post Currently ‘no plans’ to expand Pharmacy First common conditions appeared first on The Pharmacist.

New regulatory measures tightening the rules around valproate prescribing are set to come into force from January 2024, and the Medicines and Healthcare products Regulatory Agency (MHRA) is urging healthcare organisations to adequately prepare. From the new year, the first phase of the new measures will curb the use of valproate in new male or The post Plan now for upcoming valproate prescribing rule changes, instructs MHRA appeared first on The Pharmacist.

The vaccine may be less effective in protecting against flu, if administered after the amended expiry date AstraZeneca UK has revised the expiry dates for certain batches of Fluenz Tetra nasal spray vaccines as a precautionary measure, after finding that their potency (strength) dropped faster than predicted once thawed, during routine testing. The Medicines and <p>The post AstraZeneca UK amends ‘incorrect’ expiry dates of flu nasal spray vaccines first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

Each webinar will have policy experts from NHS England and CPPE  Community Pharmacy England (CPE) is organising a series of webinars to help pharmacy owners and their teams to prepare for the implementation of new Pharmacy First service, and changes to the Contraception and Hypertension Case-Finding Services. Beginning from 5th December, the webinars would be <p>The post CPE launces new webinar series to support implementation of Pharmacy First service first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

The 5% pay award for NHS nursing staff in England appears “increasingly inadequate” to keep up with inflation The Royal College of Nursing (RCN) has expressed “extreme disappointment” that the UK government offered new pay to NHS consultants, while nursing pay deal remain disputed. RCN General Secretary and Chief Executive Pat Cullen has written to <p>The post Nurses demand fresh negotiations following NHS consultant pay offer first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

Scientists at King’s College London and bit.bio are collaborating to develop multi-cell models of the human brain which will be vital to progress scientific understanding, screen for new treatments and develop novel therapies for neuronal and psychiatric disorders such as schizophrenia. Professor Deepak Srivastava and Dr Anthony Vernon will create different bi- and tri-cell models

Viruses that cause flu and Covid spread more easily as it gets colder, warns NHS England director, Roz Lindridge The National Health Service (NHS) has reminded people in Midlands that online bookings for winter vaccines will be closed in two weeks. Those who are eligible for flu and Covid vaccines are encouraged to go online <p>The post People in Midlands asked to book winter vaccines by 14 December first appeared on Latest Pharmacy News | Business | Magazine - Pharmacy Business.</p>

Researchers from the University of Birmingham have designed and developed a novel diagnostic device to detect traumatic brain injury (TBI) by shining a safe laser into the eye. Described in Science Advances, the technique is dramatically different from other diagnostic methods and is expected to be developed into a hand-held device for use in the

The NHS Confederation and the Association of the British Pharmaceutical Industry (ABPI) have published a report Partnering with purpose: How integrated care systems and industry can work better together1, alongside a library of more than 100 case studies of successful partnerships2. The report was compiled following a series of webinars involving 60 NHS leaders representing 13

The National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s Imfinzi▼ (Durvalumab) in combination with gemcitabine and cisplatin (chemotherapy) for NHS use in England and Wales for the first-line treatment of adults with locally advanced, unresectable, or metastatic biliary tract cancer (BTC).1 There remains a significant unmet need for new treatment options in

Systemic, long-term changes to the UK’s health system are required to tackle ‘unacceptable’ inequalities in diabetes care, according to a new report. The report, from the Diabetes UK Tackling Inequality Commission, was informed by the experiences of more than 100 people with diabetes, aged 18-80, from all corners of the UK. It sets out a

Many healthcare professionals (HCPs) play an imperative role in the breast cancer pathway, and none work in isolation. It is essential that there is collaboration and partnership at every step of the journey to deliver the best possible care to all women. Following Breast Cancer Awareness Month, it seems a pertinent time to reflect on

The Biotechnology and Biological Sciences Research Council (BBSRC) is set to fund sixty-two researchers across the UK, each of whom will receive a share of £12 million to pursue novel bioscience research. From lessons in regeneration that we can learn from rejuvenating jellyfish to the effect sleep has on our genetic ageing, each of the

The National Institute for Health and Care Excellence (NICE) has recommended Chiesi’s Lamzede®▼ (velmanase alfa) in their final evaluation document as an option for treating the non-neurological signs and symptoms of mild to moderate alpha-mannosidosis1.  The treatment must be started in people under 18 years of age, and can be continued in people who turn

Clinical trials startup Lindus Health is teaming up with global lifecycle management healthcare company Pharmanovia to launch an innovative new trial to generate fresh data and insights on the safety and efficacy of licensed chloral hydrate as a short-term treatment for severe insomnia. This trial represents a significant step forward in patient-centric trial design, as

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for Eli Lilly’s TIRZEPATIDE®▼ (MOUNJARO) a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, for weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in adults with an initial

Oli Hudson, NHS Insights Director with Wilmington Healthcare’s consultancy team, explores recent NHS figures to show what the service needs from pharma. The year 2023 has been another challenging one in the Health Service. Pressure from the centre for more activity to reduce the treatment backlog and increase capacity have been constant; but workforce issues,

The government will meet its target to open 160 community diagnostic centres a year early, the Health and Social Care Secretary has announced. All 160 centres will be open by March 2024, a year ahead of the original March 2025 target – speeding up access to potentially lifesaving tests and checks. Based in a variety

Chiesi has announced the appointment of Ralph Blom as the General Manager for Chiesi Limited (covering the UK and Ireland), beginning January 2024. Ralph will succeed Tom Delahoyde, who will retire at the end of December 2023. David Garzón Lafuente will also join as the Rare Disease Business Unit Lead in January 2024. Ralph Blom

The dementia charity, Alzheimer’s Society has warned that inequality is ‘rife’ as a difference of nearly 40 percentage points in dementia diagnosis rates are reported across England.   Over 50% of local authorities in England are falling short of the national dementia diagnosis target leaving hundreds of thousands without a vital dementia diagnosis. This comes

The National Institute for Health and Care Excellence (NICE) has issued a final draft guidance (FDG) recommending Brukinsa® (zanubrutinib) for the treatment of eligible adult patients with: Untreated chronic lymphocytic leukemia (CLL) if there is a 17p deletion or TP53 mutation (high risk) or Untreated CLL without a 17p deletion or TP53 mutation, and fludarabine-cyclophosphamide-rituximab (FCR)

Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovation against antimicrobial resistance (AMR) to save lives. PACE has announced its first funding call with up to £10 million available to support innovators developing new antimicrobials. As the UK’s

Clerkenwell Health, the mental health company specialising in matching patients with cutting-edge psychiatry treatments, has announced that it is taking part in Transcend Therapeutics’ Phase 2 study evaluating the safety and efficacy of methylone in patients with severe PTSD. The clinical trials sees patients administered with methylone – a rapid-acting neuroplastogen which has short-acting and

Kyowa Kirin and Orchard Therapeutics have entered into a definitive agreement under which Kyowa Kirin will acquire Orchard Therapeutics for $16.00 per American Depositary Share (ADS) in cash (approximately $387.4 million, or ¥57.3 billion), under which Orchard shareholders will hold an additional contingent value right (CVR) of $1.00 per ADS. An additional $1.00 CVR will

AstraZeneca’s olaparib has been accepted for use within NHS Scotland by the Scottish Medicines Consortium (SMC) for use as monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline BRCA1/2 mutations, who have HER2-negative high risk early breast cancer previously treated with neoadjuvant or adjuvant chemotherapy.1 Almost 56,000 people

HypnoVR, a European leader in digital therapies to manage pain and anxiety, has acquired Belgian company Oncomfort, the inventor of Digital Sedation™, a pharmacological method of relieving patients’ pain and anxiety. The acquisition should speed up the commercial roll-out of HypnoVR’s solutions in Europe. Over 550 European healthcare facilities are now using HypnoVR technology, including

Question: I have a question about monitoring and the use of testing strips.  Not sure whether this is a good subject for one of your hints and tips emails? When a patient home monitors they will be prescribed strips and therefore an FP10 claimable. If using in the surgery can we prescribe?  I think they

Question: Thank you for the recent webinar with regards to PA VAT and Profitable Dispensing. Can you point me in the right direction to find the list of HMRC PA Items? As this has got me slightly worried on how I divide by monthly drug statements between PA Items and Dispensing items.  At the moment

Clara is one of the biggest eCDRs in the UK pharmacy market and it is time that dispensing doctors looked at their current eCDR or replaced those old fashioned and cumbersome paper CD Registers. Clara is integrated with the major pharmacy PMR computer companies : Positive Solutions, Rx Web, Titan For the pharmacy PMR integrated

For over 80 years, our award-winning team have delivered outsourced HR, employment law and health & safety services to UK businesses. We support your business compliance at all levels. Our expert UK-based advisors provide a service that is designed around the challenges or needs of your organisation. Our point of difference is that we’re not an off-the-shelf provider. We tailor our approach

A Free Half-Day Dispensing Roadshow with the Experts Greg Bull and Alastair Carmichael of Dispensing Doctor Experts, 35+ years’ experience [All events 830am registration, all events end at 2pm after a working lunch] NORFOLK George Hotel, Swaffham – 15th Nov  The following companies Lupin Healthcare, Chiesi Ltd and RidgePharma are supporting this meeting by the

Electronic prescription dispensing is set to penetrate the most remote and rural corners of England after a ground-breaking piece of software was accredited by the NHS. Titan PMR has become the first viable software to be given full release authority by the NHS to provide electronic prescription services (EPS) to dispensing doctors. As a dispensing

Contrelle Activgard is now listed in Part IX of the Drug Tariff and can now be prescribed by general practitioners. 1/3 of women are reported to suffer from stress urinary incontinence, impacting both their quantity and quality of exercise and mental health. Contrelle is a disposable bladder support, which offers a simple, self-administered approach to

Having taught the PCSE Statement webinar a few times now, and having taught it in person one to one, online and face to face, it strikes me that this is an area which is still often misunderstood. If you would like to book an online session where we go through YOUR PCSE statement, section by

For January and February we are offering one hour online training sessions for dispensary staff covering Management Accounts, PCSE Statement Explained, Principles of Dispensary Management, Dispensary Design for Profit and more. A one hour online session can be booked for as little as £200 + VAT For in house training on site at your practice

Email contact@dispensingdoctorexperts.co.uk for a FREE Sample What is neuropad® used for? Nerve damage to the feet is a common complication of diabetes but is often not noticed until it has become quite advanced and conventionally this may be picked up through a positive 10g monofilament test for lack of vital protective sensation. However late detection and

In this PSNC podcast we explore how to learn and use influencing skills to promote community pharmacy in the changing commissioning environment. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

As the NHS continues to change, LPCs need to be able to adapt to the changes and support contractors in changing times. This podcast discusses how to manage change both within and outside the LPC. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide). [...]

Learn more about mentoring, an adaptable skill that can be used within community pharmacy and beyond. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

Led by negotiation skills trainer Phil Parry this PSNC MyCoach podcast provides tips on how to avoid failure and improve success. Supported by Pfizer Limited. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

Facilitating an LPC planning meeting  or contractor meeting? This  short PSNC MyCoach podcast will sharpen skills and boost your confidence. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

For new LPC chairs or experienced chairs looking for tips and ideas – a PSNC MyCoach podcast on chairing meetings, with training consultant Phil Parry. Listen to more of our podcasts via our podcast index page or subscribe through iTunes (click here for an iTunes podcast guide).  

In this PSNC podcast we discuss why LPCs are consulted on market entry applications; what if the applicant is not an existing contractor in the LPC area; what LPCs should and shouldn’t take into account when considering an application; what about distance selling applications; governance and conflicts of interests? Listen to more of our podcasts [...]

With Rachel Harrison who leads PSNC’s Leadership Academy. Rachel discusses the qualities she has seen in some of the LPC members and officers that single them out as potential leaders. The qualities LPC leaders possess; what make people follow leaders? Key aspects of change management and coaching; the different styles of leadership? What sort of [...]